Gene · 8021
Papers1,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The cellular environment shapes the nuclear pore complex architecture. | Nature | 2021 | 34646014 | PubTator, text mining | PubMed |
| Gigantol inhibits cell proliferation and induces apoptosis by regulating DEK in non-small cell lung cancer. | Exp Ther Med | 2021 | 34630671 | PubTator, text mining | PubMed |
| Evans syndrome in adults: an observational multicenter study. | Blood Adv | 2021 | 34592758 | PubTator, text mining | PubMed |
| An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis. | Bone Marrow Transplant | 2021 | 34584240 | PubTator, text mining | PubMed |
| Significance of NPM1 Gene Mutations in AML. | Int J Mol Sci | 2021 | 34576201 | PubTator, text mining | PubMed |
| Advances in the First Line Treatment of Pediatric Acute Myeloid Leukemia in the Polish Pediatric Leukemia and Lymphoma Study Group from 1983 to 2019. | Cancers (Basel) | 2021 | 34572762 | PubTator, text mining | PubMed |
| Phosphorylation-Mediated Molecular Pathway Changes in Human Pituitary Neuroendocrine Tumors Identified by Quantitative Phosphoproteomics. | Cells | 2021 | 34571875 | PubTator, text mining | PubMed |
| Identification of early and intermediate biomarkers for ARDS mortality by multi-omic approaches. | Sci Rep | 2021 | 34556700 | PubTator, text mining | PubMed |
| [Prognostic significance of DEK-NUP214 fusion gene in patients with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation]. | Zhonghua Nei Ke Za Zhi | 2021 | 34551474 | PubTator, text mining | PubMed |
| Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH-based algorithm distinguishes prognostic groups and outcomes. | Blood Cancer J | 2021 | 34548472 | PubTator, text mining | PubMed |
| Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia. | Blood Adv | 2021 | 34547766 | PubTator, text mining | PubMed |
| Landscape Analysis of Breast Cancer and Acute Myeloid Leukemia Trials Using the My Cancer Genome Clinical Trial Data Model. | JCO Clin Cancer Inform | 2021 | 34546785 | PubTator, text mining | PubMed |
| Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins. | Front Oncol | 2021 | 34540702 | PubTator, text mining | PubMed |
| Circular RNA circ_0089153 acts as a competing endogenous RNA to regulate colorectal cancer development by the miR-198/SUMO-specific peptidase 1 (SENP1) axis. | Bioengineered | 2021 | 34516314 | PubTator, text mining | PubMed |
| Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia. | J Clin Med | 2021 | 34501239 | PubTator, text mining | PubMed |
| The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia. | J Clin Med | 2021 | 34501237 | PubTator, text mining | PubMed |
| Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia. | J Hematol Oncol | 2021 | 34479626 | PubTator, text mining | PubMed |
| Targeted Therapy in Acute Lymphoblastic Leukaemia. | J Pers Med | 2021 | 34442359 | PubTator, text mining | PubMed |
| T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness. | Genes (Basel) | 2021 | 34440292 | PubTator, text mining | PubMed |
| Quantifying the phase separation property of chromatin-associated proteins under physiological conditions using an anti-1,6-hexanediol index. | Genome Biol | 2021 | 34404448 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8021/papers?page=21